Abbreviated New Drug Application Claim
Definition
An Abbreviated New Drug Application (ANDA) Claim arises when there is a dispute or legal challenge related to the submission or approval of an ANDA, which allows for the marketing of a generic drug that demonstrates bioequivalence to an already approved brand-name drug. This claim can involve issues of patent infringement, exclusivity rights, or regulatory compliance.
Class Relationships
Parent(s)
Children 0
- • None
Class Hierarchy Visualization
Interactive graph showing class relationships - click on any node to navigate to that class
Additional Information
Metadata
Comment
None
Description
None
Notes
- • None
Editorial Information
History Note
None
Editorial Note
None
Identifier
N/A
Deprecated
No
Source and Origin
No source or origin information available